MedPath

Contrast Ultrasound Perfusion Imaging in Peripheral Arterial Disease (PAD)

Completed
Conditions
Peripheral Arterial Disease
Registration Number
NCT01377649
Lead Sponsor
Oregon Health and Science University
Brief Summary

Contrast ultrasound is a technique that can quantify blood flow in the tissues of the body by ultrasound detection of microbubble contrast agents that behave in the circulation similar to red blood cells. In this study, the investigators hypothesize that contrast ultrasound of blood flow in the leg (thigh and calf) at rest and during stress produced by medications that mimic exercise (vasodilator stress) can provide information on the location and severity of peripheral vascular disease (blockages of the blood vessels in the leg). The investigators will also determine whether symptom improvement after revascularization (procedures to open up or bypass the blockages) is directly related to the improvement in blood flow.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
18
Inclusion Criteria
  1. Known or suspected PAD
  2. Lower extremity angiography or MRA planned or performed within 6 months
Exclusion Criteria
  1. Age <19 y.o.
  2. Pregnant or lactating females
  3. Hypersensitivity to ultrasound contrast agent, dipyridamole, or regadenoson
  4. Severe reactive airways disease
  5. Evidence right-to-left shunt (identified on screening echo)
  6. NYHA Class III or IV heart failure.
  7. Planned amputation
  8. Unstable coronary artery disease or severe aortic stenosis

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Quantitation of PerfusionImmediate

Correlation of skeletal muscle perfusion with symptom status

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Oregon Health & Science University

🇺🇸

Portland, Oregon, United States

© Copyright 2025. All Rights Reserved by MedPath